(MSTX) Defiance Daily Target 1.75x - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: (N/A)
MSTX: Financial, Instruments, Swaps, Derivatives, Leverage
The Defiance Daily Target 1.75x Long MSTR ETF (NASDAQ:MSTX) is a leveraged exchange-traded fund that aims to provide 1.75 times the daily return of MicroStrategy Incorporated (MSTR). To achieve this, the fund enters into swap agreements with financial institutions, which can have a term ranging from one day to over a year, allowing it to gain exposure to the underlying securitys performance.
The funds investment strategy is focused on financial instruments that are expected to perform in line with 2X the daily performance of MSTRs shares, with a minimum exposure of 80%. As a non-diversified fund, MSTX is heavily reliant on the performance of MSTR, making it a high-risk investment. This concentration can result in significant gains or losses, depending on the direction of MSTRs stock price.
Given the current technical data, MSTX is trading at $37.00, below its 20-day SMA of $38.17, indicating a potential short-term bearish trend. However, its 50-day SMA is at $35.65, suggesting a longer-term bullish trend. The 200-day SMA at $38.99 implies a strong long-term uptrend. The ATR of 3.67 (9.92% of the last price) indicates high volatility, which is expected for a leveraged ETF. With an AUM of $1210.03M USD, the fund has a substantial asset base, which can contribute to liquidity and stability.
Forecasting MSTXs performance involves analyzing both technical and fundamental data. If MSTRs stock price continues to rise, MSTX is likely to benefit due to its leveraged long position. However, if MSTR experiences a significant decline, MSTX could suffer substantial losses. Based on the current SMA indicators, a potential short-term correction may be followed by a longer-term uptrend, assuming MSTRs stock price continues to rise. Therefore, a prudent investment strategy would be to monitor MSTRs performance closely and adjust holdings accordingly. A potential trading strategy could involve buying MSTX on dips towards the 50-day SMA and selling on rallies towards the 20-day SMA, while keeping a close eye on the overall trend and adjusting as necessary.
Additional Sources for MSTX ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
MSTX ETF Overview
Market Cap in USD | 1,210m |
Category | Trading--Leveraged Equity |
IPO / Inception | 2024-08-14 |
MSTX ETF Ratings
Growth Rating | 30.7 |
Fundamental | - |
Dividend Rating | 40.0 |
Rel. Strength | 124 |
Analysts | - |
Fair Price Momentum | 32.20 USD |
Fair Price DCF | - |
MSTX Dividends
Dividend Yield 12m | 39.63% |
Yield on Cost 5y | 97.35% |
Annual Growth 5y | -100.00% |
Payout Consistency | 100.0% |
Payout Ratio | % |
MSTX Growth Ratios
Growth Correlation 3m | 59.8% |
Growth Correlation 12m | 26.6% |
Growth Correlation 5y | 26.6% |
CAGR 5y | 149.65% |
CAGR/Max DD 5y | 1.73 |
Sharpe Ratio 12m | 0.09 |
Alpha | 126.20 |
Beta | 2.653 |
Volatility | 121.91% |
Current Volume | 4224.5k |
Average Volume 20d | 5829.1k |
As of June 16, 2025, the stock is trading at USD 37.00 with a total of 4,224,459 shares traded.
Over the past week, the price has changed by -5.18%, over one month by -11.25%, over three months by +31.35% and over the past year by +149.65%.
Neither. Based on ValueRay´s Analyses, Defiance Daily Target 1.75x is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 30.69 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MSTX is around 32.20 USD . This means that MSTX is currently overvalued and has a potential downside of -12.97%.
Defiance Daily Target 1.75x has no consensus analysts rating.
According to our own proprietary Forecast Model, MSTX Defiance Daily Target 1.75x will be worth about 38.6 in June 2026. The stock is currently trading at 37.00. This means that the stock has a potential upside of +4.41%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 38.6 | 4.4% |